Sponsor hub
Columbia University clinical trial failures
Review 94 stopped clinical trials from Columbia University, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 3 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 74
- OTHER/UNKNOWN
- 17
- EFFICACY/FUTILITY
- 2
- SAFETY
- 1
Notable sponsors
- Columbia University
- 94
Related phases
- Phase II
- 32
- Phase IV
- 21
- Phase I
- 19
- Unknown
- 9
- Phase III
- 7
Crawlable stopped-trial records
Open ExploreShowing up to 94 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase I Anemia, Sickle Cell trial by Columbia University. Stop reason: OPERATIONAL.
Closed by the industry collaborator
Phase IV HIV Lipodystrophy Syndrome trial by Columbia University. Stop reason: OTHER/UNKNOWN.
lack of availability of the study drug
Phase III Carotid Artery Stenosis trial by Columbia University. Stop reason: OPERATIONAL.
The study was terminated early due to recruitment limitations, particularly difficulty enrolling statin-naïve patients
Phase IV Postpartum Pregnancy-Induced Hypertension trial by Columbia University. Stop reason: OPERATIONAL.
Principal investigator left the institution
Phase II Chronic Obstructive Pulmonary Disease (COPD) trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Difficulty finding Annexin study drug supplier
Early Phase I Carpal Tunnel Syndrome trial by Columbia University. Stop reason: OPERATIONAL.
lack of funding
Early Phase I ACHROMATOPSIA 7 trial by Columbia University. Stop reason: OPERATIONAL.
Administrative changes
Phase IV Polycystic Ovary Syndrome trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment, administrative challenges, and lack of funding
Phase I Diffuse Intrinsic Pontine Glioma trial by Columbia University. Stop reason: OPERATIONAL.
FDA withdrew approval of the new drug application (NDA) for panobinostat as of March 24, 2022 because it was not feasible for the company to complete the required postmarketing clinical trials.
Phase II Solid Tumor trial by Columbia University. Stop reason: EFFICACY/FUTILITY.
Interim analysis indicated that futility boundary was reached.
Phase III Stroke trial by Columbia University. Stop reason: EFFICACY/FUTILITY.
The DSMB halted the trial prematurely due to futility without any safety concerns.
Phase II Acute Myeloid Leukemia trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Difficultly enrolling
Phase IV Lupus Nephritis trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase II Follicular Lymphoma trial by Columbia University. Stop reason: OPERATIONAL.
Enrollment challenges
Phase II COVID trial by Columbia University. Stop reason: OPERATIONAL.
Low enrollment.
Phase II Advanced Cutaneous Squamous Cell Carcinoma trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Departure of the original investigator
Phase I Gastrointestinal Cancer trial by Columbia University. Stop reason: SAFETY.
Toxicity and Lack of Efficacy
Phase II Cardiovascular Diseases trial by Columbia University. Stop reason: OPERATIONAL.
Early termination due to COVID-19
Phase II COVID-19 trial by Columbia University. Stop reason: OTHER/UNKNOWN.
The Institutional Review Board closed the study
Phase III Graves Disease trial by Columbia University. Stop reason: OPERATIONAL.
Low enrollment
Phase I Lymphoid Malignancies trial by Columbia University. Stop reason: OPERATIONAL.
PI left institution
Phase II Non-Small Cell Lung Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase II Heart Failure trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase I Growth Hormone Deficiency trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase II Breast Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase I Insulin Resistance trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Investigators' scientific priorities shifted.
Phase II Gastrointestinal Stromal Tumors trial by Columbia University. Stop reason: OPERATIONAL.
Study ended prematurely at the request of the funding sponsor.
Phase I Steroid Refractory GVHD trial by Columbia University. Stop reason: OPERATIONAL.
The primary reason for study closure is slow enrollment.
Early Phase I Pelvic Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Slow accrual rate due to national contrast shortage
Phase II Heart Failure trial by Columbia University. Stop reason: OPERATIONAL.
Lack of enrollment
Phase IV Overweight and Obesity trial by Columbia University. Stop reason: OTHER/UNKNOWN.
The FDA advised of a possible health risk associated with lorcaserin and the drug is being withdrawn.
Unknown Clostridium Difficile Infection trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase II Carcinoma, Non-Small-Cell Lung trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Frontline pembrolizumab approved in NSCLC as monotherapy and in combination with chemotherapy representing a new standard of care.
Phase IV Rheumatoid Arthritis trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Early Phase I Malignant Melanoma, Metastatic trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase IV Growth Hormone Deficiency trial by Columbia University. Stop reason: OPERATIONAL.
poor enrollment
Phase IV Primary Hyperparathyroidism trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase IV Cerebral Palsy trial by Columbia University. Stop reason: OPERATIONAL.
PI left institution.
Phase II COVID-19 trial by Columbia University. Stop reason: OPERATIONAL.
Study terminated due to poor enrollment. Data was not analyzed or disclosed due to subject confidentiality being an issue (n=1).
Phase II Primary Lymphedema trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase II NAFLD - Nonalcoholic Fatty Liver Disease trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase II Acute Lung Injury trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase I NASH (Nonalcoholic Steatohepatitis) trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase III Thyroid Associated Ophthalmopathies trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Early Phase I Epidermolysis Bullosa trial by Columbia University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Labor Pain trial by Columbia University. Stop reason: OPERATIONAL.
Study never started
Phase I Hodgkin Disease trial by Columbia University. Stop reason: OPERATIONAL.
PI left institution
Phase II Follicular Lymphoma trial by Columbia University. Stop reason: OPERATIONAL.
PI left institution
Phase II Pituitary Tumor trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase IV Familial Hypercholesterolemia trial by Columbia University. Stop reason: OPERATIONAL.
Terminated Prematurely due to COVID-19
Unknown Carotid Artery Disease trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase I Major Depressive Disorder trial by Columbia University. Stop reason: OPERATIONAL.
PI left the institution
Phase IV Ankylosing Spondylitis trial by Columbia University. Stop reason: OPERATIONAL.
Slow recruitment
Phase III Idiopathic Peripheral Neuropathy trial by Columbia University. Stop reason: OPERATIONAL.
Poor recruitment
Phase II Pleural Mesothelioma trial by Columbia University. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase I Lymphoma, T-Cell trial by Columbia University. Stop reason: OPERATIONAL.
Investigator left institution
Phase IV Femoroacetabular Impingement trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Unforeseen cost restrictions of the drug halted the execution of this study altogether.
Phase II Basal Cell Nevus Syndrome trial by Columbia University. Stop reason: OPERATIONAL.
Loss of funding
Phase II Sarcoma, Soft Tissue trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Closed by pharmaceutical sponsor
Unknown Obesity trial by Columbia University. Stop reason: OPERATIONAL.
Closed by sponsor. Lack of funding.
Phase IV Pain trial by Columbia University. Stop reason: OPERATIONAL.
Understaffing
Phase IV Alopecia Areata trial by Columbia University. Stop reason: OPERATIONAL.
The PI left the Columbia University Medical Center. Study was not Completed.
Phase II Heart Failure, Congestive trial by Columbia University. Stop reason: OPERATIONAL.
Terminated due to logistical barriers to cell processing and poor enrollment
Phase I Prostate Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment; PI left the institution
Phase I Leukemia trial by Columbia University. Stop reason: OPERATIONAL.
Poor accrual
Early Phase I Breast Neoplasm trial by Columbia University. Stop reason: OPERATIONAL.
Unable to enroll subjects
Phase I Evaluating Pharmacokinetics of Intranasal Ketorolac trial by Columbia University. Stop reason: OPERATIONAL.
Enrolment issues
Phase I Peripheral Vein Vasodilation trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase II Diabetes Mellitus trial by Columbia University. Stop reason: OTHER/UNKNOWN.
18F-THK5351 was reported non-specific binding of MAO receptors.
Phase II Non-small Cell Lung Cancer trial by Columbia University. Stop reason: OTHER/UNKNOWN.
PI Transferred
Unknown Esophageal Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase IV Fever trial by Columbia University. Stop reason: OTHER/UNKNOWN.
PI no longer at institution
Phase IV Hemorrhoids trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Not yet IRB approved and PI will be leaving institution in September.
Phase IV Osteoporosis trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase IV Hypertension trial by Columbia University. Stop reason: OPERATIONAL.
Terminated by Sponsor
Phase II HER-2 Positive Gastric Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Former PI left institution and had plans to continue at another institution.
Phase II Recurrent Ovarian Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Principal Investigator left institution
Unknown Sickle Cell Disease trial by Columbia University. Stop reason: OPERATIONAL.
Difficulty recruiting donors and recipients, looking for alternative sites
Phase IV Chronic Obstructive Lung Disease trial by Columbia University. Stop reason: OPERATIONAL.
Closed by study sponsor; PI left the institution; responsible party changed to Columbia
Phase I Neuroblastoma trial by Columbia University. Stop reason: OPERATIONAL.
Poor accrual
Phase III Heart Failure trial by Columbia University. Stop reason: OPERATIONAL.
PI left the institution
Phase II Epilepsy trial by Columbia University. Stop reason: OPERATIONAL.
PI left the institution.
Phase II Biliary Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Poor patient accrual
Phase IV Pain trial by Columbia University. Stop reason: OPERATIONAL.
Slow recruitment of subjects
Unknown Hepatitis C Infection trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Unknown Parkinson's Disease trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding
Phase I High Grade Sarcoma trial by Columbia University. Stop reason: OPERATIONAL.
Slow accrual
Phase II Crohn's Disease trial by Columbia University. Stop reason: OPERATIONAL.
PI left the institution
Phase II Chronic Fatigue Syndrome trial by Columbia University. Stop reason: OPERATIONAL.
PI left the institution
Unknown Pancreatic Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Poor enrollment
Phase III Hyponatremia trial by Columbia University. Stop reason: OTHER/UNKNOWN.
Unable to complete a contract with the Sponsor
Phase I Prostate Cancer trial by Columbia University. Stop reason: OPERATIONAL.
Lack of funding, PI left the institution, poor enrollment
Unknown Liver Failure trial by Columbia University. Stop reason: OPERATIONAL.
Unable to recruit sufficient participants due to lack of funding; PI has left the institution.
Phase I Epilepsy trial by Columbia University. Stop reason: OPERATIONAL.
Funding agency no longer provide support.